Latest news
Supernus, Indivior merger to create broader neuroscience portfolio - FirstWord PharmaFirstWord Pharma · Mon, 03 Aug 2026 17:16:56 GMTSupernus (SUPN) And Indivior (INDV) Merge To Form $2.2 Billion CNS Pharmaceutical Giant - londoninsider.co.uklondoninsider.co.uk · Mon, 03 Aug 2026 16:16:07 GMTSupernus, Indivior merge to strengthen neuroscience drug portfolio - ReutersReuters · Mon, 03 Aug 2026 14:41:43 GMTIndivior and Supernus Pharmaceuticals Confirm Merger Deal in August 2026 Filing - Kalkine MediaKalkine Media · Mon, 03 Aug 2026 14:28:35 GMTSupernus Shares Jump After Revenue Beat, Higher Guidance and Indivior Merger Announcement - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 12:28:16 GMTSupernus And Indivior Agree To An All-Stock Merger - FinimizeFinimize · Mon, 03 Aug 2026 12:27:13 GMTSupernus and Indivior agree to merge in all-stock deal - Investing.comInvesting.com · Mon, 03 Aug 2026 11:45:21 GMTWeekly Recap: All-stock merger with Supernus and 2026 SUBLOCADE guidance - TradingViewTradingView · Mon, 03 Aug 2026 11:33:16 GMT